Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001385417 | SCV001585254 | pathogenic | not provided | 2020-04-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu684Alafs*28) in the XPC gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant has not been reported in the literature in individuals with XPC-related conditions. This variant is present in population databases (rs765641981, ExAC 0.01%). |
Baylor Genetics | RCV003463006 | SCV004207016 | likely pathogenic | Xeroderma pigmentosum, group C | 2022-09-03 | criteria provided, single submitter | clinical testing |